Low-Dose Ketone Monoester Administration in Adults with Cystic Fibrosis: A Pilot and Feasibility Study by Plaisance, Eric P, Bergeron, Jonathan M, Bolyard, Mickey L, Hathorne, Heather Y, Graziano, Christina M, Hartzes, Anastasia, Genschmer, Kristopher R, Alvarez, Jessica A, Goss, Amy M, Gaggar, Amit, Fontaine, Kevin R

Get full text

Ataluren/ivacaftor combination therapy: Two N‐of‐1 trials in cystic fibrosis patients with nonsense mutations by Peabody Lever, Jacelyn E., Mutyam, Venkateshwar, Hathorne, Heather Y., Peng, Ning, Sharma, Jyoti, Edwards, Lloyd J., Rowe, Steven M.

Get full text

Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis by Vijaykumar, Kadambari, Leung, Hui Min, Barrios, Amilcar, Wade, Justin, Hathorne, Heather Y., Nichols, David P., Tearney, Guillermo J., Rowe, Steven M., Solomon, George M.

Get full text

Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutation by Rowe, Steven M, Liu, Bo, Hill, Aubrey, Hathorne, Heather, Cohen, Morty, Beamer, John R, Accurso, Frank J, Dong, Qunming, Ordoñez, Claudia L, Stone, Anne J, Olson, Eric R, Clancy, John P

Get full text

Ivacaftor improves rhinologic, psychologic, and sleep‐related quality of life in G551D cystic fibrosis patients by McCormick, Justin, Cho, Do‐Yeon, Lampkin, Brooks, Richman, Joshua, Hathorne, Heather, Rowe, Steven M., Woodworth, Bradford A.

Get full text

Risk factors for lung function decline in a large cohort of young cystic fibrosis patients by Cogen, Jonathan, Emerson, Julia, Sanders, Don B., Ren, Clement, Schechter, Michael S., Gibson, Ronald L., Morgan, Wayne, Rosenfeld, Margaret

Get full text

Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort by Rosenfeld, Margaret, Emerson, Julia, McNamara, Sharon, Thompson, Valeria, Ramsey, Bonnie W, Morgan, Wayne, Gibson, Ronald L

Get full text

A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus by Fernandez-Petty, Courtney M, Hughes, Gareth W, Bowers, Hannah L, Watson, John D, Rosen, Bradley H, Townsend, Stacy M, Santos, Carlo, Ridley, Caroline E, Chu, Kengyeh K, Birket, Susan E., Li, Yao, Leung, Hui Min, Mazur, Marina, Garcia, Bryan A, Evans, T Idil Apak, Libby, Emily Falk, Hathorne, Heather, Hanes, Justin, Tearney, Guillermo J, Clancy, John P, Engelhardt, John F, Swords, William E, Thornton, David J, Wiesmann, William P, Baker, Shenda M, Rowe, Steven M

Get full text

A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus by Fernandez-Petty, Courtney M., Hughes, Gareth W., Bowers, Hannah L., Watson, John D., Rosen, Bradley H., Townsend, Stacy M., Santos, Carlo, Ridley, Caroline E., Chu, Kengyeh K., Li, Yao, Leung, Hui Min, Garcia, Bryan A., Evans, T. Idil Apak, Libby, Emily Falk, Hathorne, Heather, Hanes, Justin, Tearney, Guillermo J., Engelhardt, John F., Swords, William E., Thornton, David J., Wiesmann, William P., Baker, Shenda M., Rowe, Steven M.

Get full text

Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation. e66955 by Rowe, Steven M, Liu, Bo, Hill, Aubrey, Hathorne, Heather, Cohen, Morty, Beamer, John R, Accurso, Frank J, Dong, Qunming, Ordonez, Claudia L, Stone, Anne J

Get full text

Ataluren/ivacaftor combination therapy: Two N-of-1 trials in cystic fibrosis patients with nonsense mutations by Peabody Lever, Jacelyn E, Mutyam, Venkateshwar, Hathorne, Heather Y, Peng, Ning, Sharma, Jyoti, Edwards, Lloyd J, Rowe, Steven M

Get full text